AIM The “2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial
Fibrillation” provides recommendations to guide clinicians in the treatment of patients with …

The global prevalence of atrial fibrillation (AF) has increased substantially over the past
three decades and is currently approximately 60 million cases. Incident AF and its clinical …

Despite improvements in cardiovascular care in recent decades, cardiovascular disease
(CVD) remains a leading cause of death worldwide. At its core, CVD is a largely preventable …

Cardiological disorders contribute to a significant portion of the global burden of disease.
Cardiology can benefit from Big Data, which are generated and released by different …

Objective Previous studies have found that endurance sport activity is associated with an
increased risk of atrial fibrillation (AF) in men. However, it remains unclear whether …

Atrial fibrillation (AF), the most common sustained arrhythmia in clinical practice, exhibits a
higher risk of cardiovascular adverse events. Exercise plays a crucial role in AF prevention …

Multidisciplinary cardiac rehabilitation (CR) improves the prognosis and quality of life of
patients with cardiovascular disease and has therefore received strong recommendations in …

Physical activity and moderate-to-vigorous intensity exercise provides primary1 and
secondary2 “cardio-protection.” Further, the benefits of regular exercise training go beyond …

Valproate is the most effective treatment for idiopathic generalised epilepsy. Current
guidance precludes its use in women of childbearing potential, unless other treatments are …

Background Atrial fibrillation (AF) is the most common form of clinical cardiac dysrhythmia
responsible for thromboembolic cerebral stroke, congestive heart failure, and death …